ABCG2 and ovarian cancer: Expression of BCRP and MRP3 has been detected in ovarian cancers, and these proteins have been suggested to have the ability to transport multiple anticancer agents, so these findings may be of potential clinical relevance when considering the drug treatment regimens for ovarian cancers [38,39].